Bupropion Hydrochloride
Product Images NDC 53002-1495

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 53002-1495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of bupropion hydrochloride, illustrating the molecular arrangement including a chlorophenyl ring, tert-butyl group, keto group, and hydrochloride salt.*

FDA Label Image

Label Image (Lbl530021495)

Label for Bupropion Hydrochloride XL 150 mg 24-hour extended-release tablets, manufactured by RPK Pharmaceuticals, Inc. The label indicates 30 tablets per container with directions to take one tablet daily or as directed. The label includes patient information, lot number, expiration date, and space for clinic details and prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.